Perceptive Advisors’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Perceptive Advisors’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-57,825	Closed	-$1.28M	–	238
2016 Q4	$1.28M	Sell	57,825 -206,289	-78%	-$3.86M	0.09%	90
2016 Q3	$4.88M	Sell	264,114 -5,886	-2%	-$102K	0.32%	70
2016 Q2	$4.39M	Hold	270,000	–	–	0.3%	65
2016 Q1	$3.81M	Hold	270,000	–	–	0.33%	68
2015 Q4	$4.6M	Hold	270,000	–	–	0.34%	55
2015 Q3	$5.58M	Buy	270,000 +70,000	+35%	+$1.44M	0.45%	51
2015 Q2	$3.07M	Sell	200,000 -150,000	-43%	-$2.11M	0.18%	82
2015 Q1	$4.7M	Hold	350,000	–	–	0.37%	54
2014 Q4	$4.91M	Buy	+350,000	New	+$2.77M	0.41%	55

Other funds holding NDRM

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Perceptive Advisors's NDRM Position: Q1 2017 in Review

Perceptive Advisors sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q1 2017, closing a stake of 57,825 shares — an estimated $1.28M sold.

Perceptive Advisors first reported a position in NDRM in Q4 2014 and held it in 9 quarters. The position peaked at $5.58M in Q3 2015. 70 funds tracked by Wall St. Rank hold NDRM as of Q1 2017.

Perceptive Advisors reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q1 2017 after selling out during the quarter.
Perceptive Advisors sold 57,825 NeuroDerm Ltd. Ordinary Shares shares in Q1 2017, an estimated $1.28M.
Perceptive Advisors first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2014 and held it in 9 quarters.
Perceptive Advisors's NeuroDerm Ltd. Ordinary Shares position peaked at $5.58M in Q3 2015.
70 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q1 2017.

Based on Perceptive Advisors's 13F filing for Q1 2017, filed 15 May 2017.